Terms: = Bone cancer AND SMARCA4, hSNF2b, 6597, P51532, BRG1, SNF2L4, SNF2, SWI2, FLJ39786, BAF190, SNF2LB, SNF2-BETA, ENSG00000127616
46 results:
1. [Clinical characteristics and prognosis analysis of 17 cases of smarca4-deficient chest tumors].
Cao XN; Li Z; Wang QY
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Apr; 47(4):325-331. PubMed ID: 38599807
[No Abstract] [Full Text] [Related]
2. [Cytopathological characteristics of smarca4-deficient thoracic undifferentiated tumors in serous effusion].
Wang WN; Liu XT; Liang YM
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
[No Abstract] [Full Text] [Related]
3. A CIC-related-epigenetic factors-based model associated with prediction, the tumor microenvironment and drug sensitivity in osteosarcoma.
Yu B; Geng C; Wu Z; Zhang Z; Zhang A; Yang Z; Huang J; Xiong Y; Yang H; Chen Z
Sci Rep; 2024 Jan; 14(1):1308. PubMed ID: 38225273
[TBL] [Abstract] [Full Text] [Related]
4. Characterization of a Preclinical In Vitro Model Derived from a smarca4-Mutated Sinonasal Teratocarcinosarcoma.
Lorenzo-Guerra SL; Codina-Martínez H; Suárez-Fernández L; Cabal VN; García-Marín R; Riobello C; Vivanco B; Blanco-Lorenzo V; Sánchez-Fernández P; López F; Llorente JL; Hermsen MA
Cells; 2023 Dec; 13(1):. PubMed ID: 38201285
[TBL] [Abstract] [Full Text] [Related]
5. MC180295 is a highly potent and selective CDK9 inhibitor with preclinical in vitro and in vivo efficacy in cancer.
Zhang H; Huang C; Gordon J; Yu S; Morton G; Childers W; Abou-Gharbia M; Zhang Y; Jelinek J; Issa JJ
Clin Epigenetics; 2024 Jan; 16(1):3. PubMed ID: 38172923
[TBL] [Abstract] [Full Text] [Related]
6. PROTAC-Based Protein Degradation as a Promising Strategy for Targeted Therapy in Sarcomas.
Mancarella C; Morrione A; Scotlandi K
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003535
[TBL] [Abstract] [Full Text] [Related]
7. Osteosarcoma's genetic landscape painted by genes' mutations.
Urban W; Krzystańska D; Piekarz M; Nazar J; Jankowska A
Acta Biochim Pol; 2023 Sep; 70(3):671-678. PubMed ID: 37717265
[TBL] [Abstract] [Full Text] [Related]
8. Diagnostic algorithm for challenging blue cell sinonasal carcinoma.
Laforga JB; Abdullah B
Pathol Res Pract; 2023 Aug; 248():154683. PubMed ID: 37478521
[TBL] [Abstract] [Full Text] [Related]
9. Concurrent high-grade glioma with cavernous malformations and pathogenic variants in PDCD10 and smarca4.
Glanz H; Damodharan SN; Smith-Simmer K; Helgager J; Puccetti D
Childs Nerv Syst; 2023 Nov; 39(11):3311-3315. PubMed ID: 37328659
[TBL] [Abstract] [Full Text] [Related]
10. ZNF384-Related Fusion Genes in Acute Lymphoblastic Leukemia.
Zhu L; Bai W; Cheng Q; Fang J
Cancer Control; 2023; 30():10732748231182787. PubMed ID: 37306722
[TBL] [Abstract] [Full Text] [Related]
11. [Thoracic smarca4-deficient undifferentiated tumor resembling malignant lymphoma].
Asou C; Maeda T; Yamaguchi O; Okamura D; Ishikawa M; Kohri M; Tsukasaki K; Matsuda A; Asou N; Satoh T; Kayano H; Takahashi N
Rinsho Ketsueki; 2023; 64(4):271-276. PubMed ID: 37121771
[TBL] [Abstract] [Full Text] [Related]
12. Molecular markers of metastatic disease in KRAS-mutant lung adenocarcinoma.
Boiarsky D; Lydon CA; Chambers ES; Sholl LM; Nishino M; Skoulidis F; Heymach JV; Luo J; Awad MA; Janne PA; Van Allen EM; Barbie DA; Vokes NI
Ann Oncol; 2023 Jul; 34(7):589-604. PubMed ID: 37121400
[TBL] [Abstract] [Full Text] [Related]
13. ERCC6L2-related disease: a novel entity of bone marrow failure disorder with high risk of clonal evolution.
Baccelli F; Leardini D; Cerasi S; Messelodi D; Bertuccio SN; Masetti R
Ann Hematol; 2023 Apr; 102(4):699-705. PubMed ID: 36790458
[TBL] [Abstract] [Full Text] [Related]
14. Fine needle aspiration cytology of metastatic smarca4-deficient sinonasal teratocarcinosarcoma: First report in literature.
Gopakumar A; Kakkar A; Kaur K; Sikka K; Thakar A; Sharma A; Jain D
Diagn Cytopathol; 2023 Apr; 51(4):E129-E136. PubMed ID: 36680532
[TBL] [Abstract] [Full Text] [Related]
15. SWI/SNF-deficient Sinonasal Carcinomas.
Agaimy A
Adv Anat Pathol; 2023 Mar; 30(2):95-103. PubMed ID: 36580412
[TBL] [Abstract] [Full Text] [Related]
16. Label-Free Direct Mass Spectrometry Analysis of the Bystander Effects Induced in Chondrocytes by Chondrosarcoma Cells Irradiated with X-rays and Carbon Ions.
Gilbert A; Payet V; Bernay B; Chartier-Garcia E; Testard I; Candéias SM; Chevalier F
Front Biosci (Landmark Ed); 2022 Sep; 27(9):277. PubMed ID: 36224025
[TBL] [Abstract] [Full Text] [Related]
17. [Mesenchymal chondrosarcoma in central nervous system: a clinicopathological analysis].
Huang Q; Chen YP; Song FL; Zheng LM; Liu XY; Zhang S; Wang XF
Zhonghua Bing Li Xue Za Zhi; 2021 Aug; 50(8):870-875. PubMed ID: 34344069
[No Abstract] [Full Text] [Related]
18. NUT carcinoma of the lung.
Lantuejoul S; Pissaloux D; Ferretti GR; McLeer A
Semin Diagn Pathol; 2021 Sep; 38(5):72-82. PubMed ID: 34176698
[TBL] [Abstract] [Full Text] [Related]
19. Mutational profile of ZBTB16-RARA-positive acute myeloid leukemia.
Fabiani E; Cicconi L; Nardozza AM; Cristiano A; Rossi M; Ottone T; Falconi G; Divona M; Testi AM; Annibali O; Castelli R; Lazarevic V; Rego E; Montesinos P; Esteve J; Venditti A; Della Porta M; Arcese W; Lo-Coco F; Voso MT
Cancer Med; 2021 Jun; 10(12):3839-3847. PubMed ID: 34042280
[TBL] [Abstract] [Full Text] [Related]
20. Relevance of Molecular Groups in Children with Newly Diagnosed Atypical Teratoid Rhabdoid Tumor: Results from Prospective St. Jude Multi-institutional Trials.
Upadhyaya SA; Robinson GW; Onar-Thomas A; Orr BA; Johann P; Wu G; Billups CA; Tatevossian RG; Dhanda SK; Srinivasan A; Broniscer A; Qaddoumi I; Vinitsky A; Armstrong GT; Bendel AE; Hassall T; Partap S; Fisher PG; Crawford JR; Chintagumpala M; Bouffet E; Gururangan S; Mostafavi R; Sanders RP; Klimo P; Patay Z; Indelicato DJ; Nichols KE; Boop FA; Merchant TE; Kool M; Ellison DW; Gajjar A
Clin Cancer Res; 2021 May; 27(10):2879-2889. PubMed ID: 33737307
[TBL] [Abstract] [Full Text] [Related]
[Next]
